[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369851-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369851-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","revisionist-history-uncovers-a-simplified-molecular-based-classification-of-differentiated-thyroid-cancer","Revisionist history uncovers a simplified molecular-based classification of differentiated thyroid cancer","","Differentiated thyroid cancer diagnosis has long been debated among pathologists due to substantial interobserver variability, which has grown as tumor categories expand. Molecular studies indicate a clearer framework that groups lesions into RAS-like and BRAF p.V600E-like neoplasms. This review argues for a classification grounded in, but not dependent on, confirming molecular alterations, supporting pattern-based evaluation of growth and cytologic atypia. The proposal aims to simplify conceptual understanding and assist preoperative risk stratification and tumor diagnosis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/revisionist-history-uncovers-a-simplified-molecular-based-classification-of-differentiated-thyroid-cancer/369851/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/revisionist-history-uncovers-a-simplified-molecular-based-classification-of-differentiated-thyroid-cancer/369851.png","ImageObject",300,407,{"name":42,"@type":43},"4398046744996","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why has differentiated thyroid cancer classification been controversial?","Question",{"text":63,"@type":64},"Because diagnostic decisions among pathologists show high interobserver variability, and classification complexity increased with expanding tumor types and subtypes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What molecular grouping does the review emphasize?",{"text":68,"@type":64},"Lesions can be categorized into RAS-like and BRAF p.V600E-like neoplasms based on molecular studies.",{"name":70,"@type":61,"acceptedAnswer":71},"Does the proposed approach require molecular test confirmation?",{"text":72,"@type":64},"No. The review proposes a classification based on molecular alterations, but does not require confirmation of those alterations to be used in assessment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369851,1790216545,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":11,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":133,"file_id":134,"file_url":135,"file_type":136,"file_size":137,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":138,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":113,"preview_page_count":33,"preview_urls":144},4398046744996,"Journal of Pathology  \nJ Pathol October 2025; 267: 130–141  \nPublished online 5 August 2025 in Wiley Online Library (wi[leyonlinelibrary.com](leyonlinelibrary.com) DOI: 10.1002/path.6456)[)](leyonlinelibrary.com) DOI: 10.1002/path.6456)[ DOI:](leyonlinelibrary.com) DOI: 10.1002/path.6456)[ 10.1002/path.6456](leyonlinelibrary.com) DOI: 10.1002/path.6456)  \nPERSPECTIVE  \nRevisionist history uncovers a simpliﬁed molecular-based classiﬁcation of differentiated thyroid cancer  \nSylvia L Asa 1 *, Zubair Baloch2, Chan Kwon Jung3, Nicole A Cipriani4, Armando Gamboa-Domínguez5, C Christofer Juhlin6,7, Nicole D Riddle8, Ivan J Stojanov9 and Ozgur Mete 10  \n1 University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, OH, USA  \n2 University of Pennsylvania Medical Center – Perelman School of Medicine, Philadelphia, PA, USA  \n3 Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea  \n4 Department of Pathology, The University of Chicago, Chicago, IL, USA  \n5 Departamento de Patología, Instituto Nacional de Ciencias Médicas y Nutricin Salvador Zubirán, Mexico  \n6 Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden  \n7 Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden  \n8 Tampa General Hospital, University of South Florida, Ruffolo, Hooper, and Associates, Tampa, FL, USA  \n9 Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA  \n10 Department of Pathology, University Health Network, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada  \n*Correspondence to: SL Asa, University Hospitals Cleveland Medical Center, Case Western Reserve University, 11100 Euclid Avenue, Institute of  \nPathology Room 212C, Cleveland, OH 44106, [USA. E-mail:](USA. E-mail: pathlady01@gmail.com)[ pathlady01@gmail.com](USA. E-mail: pathlady01@gmail.com)  \nAbstract  \nThe diagnostic classiﬁcation of differentiated thyroid cancer has been a longstanding topic of debate among pathologists, largely due to high interobserver variability. This complexity has increased with the expansion of tumor types and subtypes. However, molecular studies have revealed a simpler and less controversial approach, categorizing these lesions into RAS-like and BRAF p.V600E-like neoplasms. In this review, the authors propose a classiﬁcation that is based on, but does not require, the conﬁrmation of molecular alterations. This approach aligns with and helps inform the pattern-based assessment of tumor growth and cytologic atypia that is already widely used in clinical practice for preoperative patient stratiﬁcation and tumor diagnosis, and promises a simpler conceptual understanding.  \n©2025 The Author(s). TheJournal of Pathology published byJohn Wiley &Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.  \nKeywords: thyroid carcinoma; classiﬁcation; molecular; morphology; immunohistochemistry; Papillary thyroid carcinoma; follicular thyroid carcinoma; invasion; nuclear atypia  \nReceived 4 April 2025; Revised 2 June 2025; Accepted 25 June 2025 No conﬂicts of interest were declared.  \nScope of the problem  \nThyroid nodules are common and can be detected in up to 60% of the population, depending on the diagnostic method employed. Their prevalence is highest in females, older individuals, those in iodine-deﬁcient regions, and those exposed to ionizing radiation [1–4] . Cytopathology and surgical pathology play a central role in diagnosing these lesions and represent the most frequent specimens in endocrine pathology. However, to date uniform diagnosis of follicular patterned thyroid nodules remains one of the most highly controversial topics in pathology, with signiﬁcant inter-and intraobserver variation [5–12] . While the ﬁeld has been considered complex, advances in the molecular proﬁling of thyroid lesions provide opportunities for sim","cbCaivqfen0IgTzw","https://ap.wps.com/l/cbCaivqfen0IgTzw","pdf",11837651,12,"English","# Scope of the problem\n# This discussion will focus on\n# Historical perspectives: understanding how we got here","[{\"question\":\"Why has differentiated thyroid cancer classification been controversial?\",\"answer\":\"Because diagnostic decisions among pathologists show high interobserver variability, and classification complexity increased with expanding tumor types and subtypes.\"},{\"question\":\"What molecular grouping does the review emphasize?\",\"answer\":\"Lesions can be categorized into RAS-like and BRAF p.V600E-like neoplasms based on molecular studies.\"},{\"question\":\"Does the proposed approach require molecular test confirmation?\",\"answer\":\"No. The review proposes a classification based on molecular alterations, but does not require confirmation of those alterations to be used in assessment.\"}]","Revisionist history uncovers a simplified molecular-based classification of differentiated thyroid cancer | PDF",1790184863,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d950eec1945a3750633defebfabee22.webp",983,1390,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a19d27c41a5014c7dbd8038e29c5736.webp",982,1388,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9a7ac60e1061577a010fbea27386e2ea.webp",981,1387,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f4f7a1bc3e03407177f70bb589b645e.webp",980,1385]